세계의 말초혈관 디바이스 시장 규모는 2034년까지 CAGR 8.5%로 성장할 것으로 예측되고 있습니다.
R&D 투자가 업계 성장을 촉진 :
시장 참여 기업은 혁신적인 말초혈관 디바이스를 제조하기 위한 R&D 투자에 참여하고 있으며, 유효성과 안전성을 높이는 것과 동시에 새로운 기술 및 치료법의 도입을 통해 사회적 인지도를 높이는 것을 목표로 하고 있습니다. 예를 들면 Medtronic은 2024년 3월, 5년간 3억 5,000만 달러 이상을 투자한다고 하는 커미트먼트의 일환으로서 Hyderabad에 있는 Medtronic Engineering and Innovation Center(MEIC)를 확장했습니다. 이 투자는 센터의 R&D 능력을 강화하고, 직원을 약 950명으로부터 1,500명으로 늘리는 것을 목적으로 하고 있습니다. 또한 2023년 12월 1일, BIOTRONIK는 최신 아시아태평양 제조·연구 허브 준공식을 시행했습니다. 20,000평방미터에 달하는 이 시설은 BIOTRONIK의 아시아태평양 제조, R&D, 판매·마케팅을 포함한 사업의 주요 센터로 지정되어 있습니다. 이 새로운 시설은 IC(interventional cardiology), 말초 인터벤션, 심장박동관리, 내시경, 신경조절, 비뇨기와 골반 건강 등 다양한 치료 영역에 걸친 전문성에 기여하며, 인도에서 Boston Scientific의 존재감과 능력을 강화합니다.
제품 리콜이 업계의 성장에 과제 :
말초혈관 디바이스 시장의 성장은 제품 리콜, 소비자 신뢰 저하, 규제 당국의 감시 강화, 제조업체에 대한 재정적 부담 증가 시장 경쟁 심화 등으로 인해 크게 저해되고 있습니다. 제품 리콜은 해당 브랜드 및 제품 카테고리에 대한 신뢰를 떨어뜨려 환자와 의료 서비스 프로바이더 수요를 감소시키고 유사한 기기의 사용을 꺼리게 만듭니다. 규제기관은 더 엄격한 승인 요건을 부과할 수 있으며, 이는 신제품 시장 진입을 지연시킬 수 있습니다. 또한 제조업체는 리콜, 조사, 피해자에 대한 보상과 관련된 막대한 비용을 부담하게 되어 수익성과 R&D 투자에 영향을 미칠 수 있습니다. 경쟁사들은 더 안전하다고 여겨지는 대체 제품을 제공함으로써 시장 점유율을 확보할 수 있는 기회를 포착하여 시장 경쟁을 심화시킬 수 있습니다.
세계의 말초혈관 디바이스 시장을 조사했으며, 시장 개요, 시장 성장에 대한 영향요인 및 시장 기회의 분석, 시장 규모의 추이·예측, 제품·최종사용자 등의 각종 구분 및 지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 리포트의 개요
제2장 주요 요약
제3장 시장 개요
주요 조사 결과
시장 역학
시장 촉진요인
시장 억제요인
시장 기회
COVID-19의 영향 분석
Porter's Five Forces 분석
PEST 분석
제4장 말초혈관 디바이스 시장 분석 : 제품별
주요 조사 결과
시장 매력 지수
시장 규모의 추이·예측
스텐트
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
베어메탈 스텐트
약물 용출 스텐트
PTA 풍선
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
카테터
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
혈관조영카테터
IVUS/OCT 카테터
가이드 카테터
혈관내 동맥류 수복 스텐트 그라프트
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
흉부 혈관내 동맥류 스텐트 그라프트
복부 혈관내 동맥류 스텐트 그라프트
플라크 수정 디바이스
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
아테렉토미 디바이스
혈전 제거 디바이스
하대정맥 필터
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
영구 필터
취득 가능한 필터
혈행동태 혈류조절 디바이스
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
만성 완전 폐색 디바이스
색전보호 디바이스
기타
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
가이드와이어
혈관 폐쇄 디바이스
풍선 팽창 디바이스
인트로듀서시스
제5장 말초혈관 디바이스 시장 분석 : 최종사용자별
주요 조사 결과
시장 매력 지수
시장 규모의 추이·예측
병원
외래 수술 센터(ASC)
기타
시장 규모의 추이·예측 : 지역별
시장 점유율 : 지역별
제6장 말초혈관 디바이스 시장 분석 : 지역별
주요 조사 결과
시장 규모의 추이·예측
제7장 북미의 말초혈관 디바이스 시장 분석
제8장 유럽의 말초혈관 디바이스 시장 분석
제9장 아시아의 말초혈관 디바이스 시장 분석
제10장 라틴아메리카의 말초혈관 디바이스 시장 분석
제11장 중동 및 아프리카의 말초혈관 디바이스 시장 분석
제12장 기업 개요
경쟁 구도
전략적 전망
Becton Dickinson and Co.(BD)
Cook Group, Inc.
Boston Scientific Corporation
Abbott Laboratories
Medtronic Plc
Getinge AB
Cardinal Health, Inc.
Terumo Corporation
Biotronik SE &Co. KG
Kyoto Medical Planning Co. Ltd.
Koninklijke Philips N.V.
B. Braun SE
Penumbra Inc.
Merit Medical Systems, Inc.
Cordis Corporation
제13장 결론·제안
Visiongain으로부터의 결론
참여 기업에 대한 권장사항
KSA
영문 목차
영문목차
The global Peripheral Vascular Devices market is projected to grow at a CAGR of 8.5% by 2034
The Peripheral Vascular Devices Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
R&D Investments Projected to Drive Industry Growth
Market participants are engaging in R&D investment to manufacture innovative peripheral vascular devices, aiming to enhance their effectiveness and safety while also raising public awareness through the introduction of new technologies and treatments. For instance, in March 2024, Medtronic expanded its Medtronic Engineering and Innovation Center (MEIC) in Hyderabad as part of its commitment to invest over $350 million over five years. This investment is intended to bolster the research and development capabilities of the center and increase its workforce from approximately 950 employees to 1,500. On 1st December 2023, BIOTRONIK unveiled the inauguration of its latest Asia Pacific Manufacturing and Research Hub. Spanning 20,000 m2, the site is designated as the primary center for BIOTRONIK's operations including manufacturing, R&D, and sales & marketing in the Asia Pacific region. This new facility will contribute expertise across various therapy domains, including interventional cardiology, peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation, and urology and pelvic health, thereby strengthening Boston Scientific's presence and capabilities in India.
Product Recall Likely to Challenge Industry Growth
The market growth of peripheral vascular devices has been significantly hampered by product recalls, eroding consumer trust, heightening regulatory scrutiny, imposing financial burdens on manufacturers, and intensifying market competition. In 2023, Cordis US Corp recalled the INFINITI Angiographic Catheter due to shipment without proper sterilization procedures, while Terumo Aortic recalled specific lots of the TREO Abdominal Stent-Graft Systems due to potential issues with graft sizes. Similarly, in April 2024, the FDA issued a Class I Recall for 330,000 Radial Artery Catheterization Kits manufactured by Teleflex and Arrow International. A total of 334,995 affected devices were distributed between December 2021 and January 2024.
These recalls undermine confidence in affected brands or product categories, leading to decreased demand and reluctance to use similar devices among patients and healthcare providers. Regulatory agencies may impose stricter approval requirements, slowing down the entry of new products into the market. Manufacturers incur significant costs related to recalls, investigations, and compensating affected individuals, impacting profitability and research and development investments. Competitors may seize the opportunity to gain market share by offering perceived safer alternatives, heightening competition within the peripheral vascular devices market.
What Questions Should You Ask before Buying a Market Research Report?
How is the peripheral vascular devices market evolving?
What is driving and restraining the peripheral vascular devices market?
How will each peripheral vascular devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each peripheral vascular devices submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading peripheral vascular devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the peripheral vascular devices projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of peripheral vascular devices projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the peripheral vascular devices market?
Where is the peripheral vascular devices market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the peripheral vascular devices market today, and over the next 10 years:
Our 325-page report provides 150 tables and 240 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the peripheral vascular devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising peripheral vascular devices prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles and for some of the leading companies in the Peripheral Vascular Devices Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth
Abbott Laboratories
B. Braun SE
Becton, Dickinson and Company
Biotronik SE & Co KG
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group, Inc.
Cordis Corp.
Getinge AB
Koninklijke Philips N.V.
Kyoto Medical Planning Co., Ltd.
Medtronic plc
Merit Medical Systems, Inc.
Penumbra Inc.
Terumo Corporation
Overall world revenue for Peripheral Vascular Devices Market, 2024 to 2034 in terms of value the market will surpass US$12.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Peripheral Vascular Devices Market, 2024 to 2034 report help you?
In summary, our 320+ page report provides you with the following knowledge:
Revenue forecasts to 2034 for Peripheral Vascular Devices Market, 2024 to 2034, with forecasts for product and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Peripheral Vascular Devices Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Peripheral Vascular Devices Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Peripheral Vascular Devices Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Peripheral Vascular Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Reimbursement for Peripheral Vascular Procedures
3.2.1.2 Rising Prevalence of Diabetic and Obesity Population is Driving the Market
3.2.1.3 Increasing Demand for Minimally Invasive Procedures
3.2.1.4 Rising Geriatric Population
3.2.2 Market Restraining Factors
3.2.2.1 Product Recalls Likely to Restrain Industry Growth
3.2.2.2 Stringent Regulations Limit the Market Growth
3.2.2.3 High Cost of Peripheral Vascular Devices Restraining the Market Growth
3.2.2.4 Availability of Substitute Treatments
3.2.3 Market Opportunities
3.2.3.1 Technological Advancements
3.2.3.2 New Product Launches is Expected to Drive the Market in Near Future
3.2.3.3 Increasing R&D Activities for Novel Device Launch
3.2.3.4 Growing Awareness and Access to Healthcare
3.3 COVID-19 Impact Analysis
3.4 Porter's Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Peripheral Vascular Devices Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Peripheral Vascular Devices Market Size Estimation and Forecast by Product
4.4 Stents
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.3 Bare Metal Stents
4.4.3.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.3.2 Market Share by Region, 2024 & 2034 (%)
4.4.4 Drug-eluting Stents
4.4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 PTA Balloons
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Catheters
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.6.3 Angiography Catheters
4.6.3.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.3.2 Market Share by Region, 2024 & 2034 (%)
4.6.4 IVUS/OCT Catheters
4.6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.4.2 Market Share by Region, 2024 & 2034 (%)
4.6.5 Guiding Catheters
4.6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.5.2 Market Share by Region, 2024 & 2034 (%)
4.7 Endovascular Aneurysm Repair Stent Grafts
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.7.3 Thoracic Endovascular Aneurysm Stent Grafts
4.7.3.1 Market Size by Region, 2024-2034 (US$ Billion)
